| BIO |
Bio-Rad Laboratories, Inc. |
72%
|
Reciprocal relationship from BIO graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from BIO graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from BIO grap… |
| BIO |
Bio-Rad Laboratories, Inc. |
72%
|
. Royalty expense is primarily recorded in cost of sales, with a small portion recorded as research and development expense depending on the use of the technology under license. Some of these agreeme… |
| IDXG |
Interpace Biosciences, Inc. |
72%
|
Reciprocal relationship from IDXG graph: entific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche AG. While we have developed alternate sourcing strategies for most of these materials and … |
| MANU |
Manchester |
72%
|
emissions, we invested in equipping our Hilden, Germany facility with an emergency power supply and renewable heating systems. Capital expenditures for property, plant and equipment totaled $167.2 mi… |
| MANU |
Manchester |
72%
|
Reciprocal relationship from MANU graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from MANU graph: Reciprocal relationship from QGEN graph: emissions, we invested in equipping… |
| PACB |
Pacific Biosciences of California, Inc. |
72%
|
Reciprocal relationship from PACB graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key man… |
| SAPGF |
SAP SE |
72%
|
Reciprocal relationship from SAPGF graph: Reciprocal relationship from QGEN graph: lity issues, we use long-term supply contracts as needed. In 2025, markets are experiencing increased pressure due t… |
| SAPGF |
SAP SE |
72%
|
lity issues, we use long-term supply contracts as needed. In 2025, markets are experiencing increased pressure due to ongoing geopolitical tensions, especially within Asia. The Company’s strong mater… |
| STQN |
Strategic Acquisitions, Inc. |
72%
|
expand operations or integrate acquisitions could negatively impact our business and financial performance. We have grown significantly in recent years, with total net sales increasing from $1.87 bil… |
| STQN |
Strategic Acquisitions, Inc. |
72%
|
Reciprocal relationship from STQN graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from STQN graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from STQN g… |
| VCYT |
Veracyte, Inc. |
72%
|
Reciprocal relationship from VCYT graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from VCYT graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from VCYT g… |
| ACTOME-GMBH |
ACTOME-GMBH |
62%
|
y. For the years ended December 31, 2025 , 2024 and 2023 , depreciation and amortization expense totaled $ 95.8 million , $ 91.5 million and $ 85.6 million , respectively. For the years ended Decembe… |
| AMERICA-HOLDINGS |
AMERICA-HOLDINGS |
62%
|
. Based on the current estimate of potential milestone payments, $ 16.2 million is included in accrued and other current liabilities and $ 6.6 million is included in other long-term liabilities in th… |
| APIS-ASSAY-TECHNOLOGIES-LTD |
APIS-ASSAY-TECHNOLOGIES-LTD |
62%
|
y. For the years ended December 31, 2025 , 2024 and 2023 , depreciation and amortization expense totaled $ 95.8 million , $ 91.5 million and $ 85.6 million , respectively. For the years ended Decembe… |
| C-ORGANIZATIONAL-STRUCTURE-MR-COMPANY |
C-ORGANIZATIONAL-STRUCTURE-MR-COMPANY |
62%
|
's internal control over financial reporting as of December 31, 2025 . Its reports are included in this Annual Report on Form 20-F beginning on page 91 . QIAGEN N.V. | Financial Report 2025 Managemen… |
| DELAWARE-GENERAL-CORPORATION |
DELAWARE-GENERAL-CORPORATION |
62%
|
. We have eight defined benefit, non-contributory retirement or termination plans that cover certain employees in Germany, France, Italy, Japan, Poland, Philippines and the United Arab Emirates. Thes… |
| EQUINITI-TRUST-COMPANY-LLC |
EQUINITI-TRUST-COMPANY-LLC |
62%
|
. We have eight defined benefit, non-contributory retirement or termination plans that cover certain employees in Germany, France, Italy, Japan, Poland, Philippines and the United Arab Emirates. Thes… |
| EY-GMBH |
EY-GMBH |
62%
|
ries of the Company’s tax advisors. We inspected the Company’s legal composition to identify and assess changes in operating structures and financing arrangements, and we inspected a selection of int… |
| GNX-DATA-SYSTEMS-LTD |
GNX-DATA-SYSTEMS-LTD |
62%
|
. We incurred $ 4.5 million acquisition related costs to effect the business combination during the year ended December 31, 2025 which is included in restructuring, acquisition, integration and other… |
| HOMBRECHTIKON-SYSTEMS-ENGINEERING-AG |
HOMBRECHTIKON-SYSTEMS-ENGINEERING-AG |
62%
|
y. For the years ended December 31, 2025 , 2024 and 2023 , depreciation and amortization expense totaled $ 95.8 million , $ 91.5 million and $ 85.6 million , respectively. For the years ended Decembe… |
| LABCORP-GENETICS-INC |
LABCORP-GENETICS-INC |
62%
|
. Based on the current estimate of potential milestone payments, $ 16.2 million is included in accrued and other current liabilities and $ 6.6 million is included in other long-term liabilities in th… |
| LLP-WELLINGTON-INVESTMENT-ADVISORS-HOLDINGS |
LLP-WELLINGTON-INVESTMENT-ADVISORS-HOLDINGS |
62%
|
. (2) The 20,678,987 shares attributed to BlackRock, Inc. are reported as of January 31, 2026. Of the 20,678,987 shares attributed to BlackRock Inc. , it has sole voting power over 19,575,569 and sol… |
| OPERATING-ENVIRONMENT-COMPANY |
OPERATING-ENVIRONMENT-COMPANY |
62%
|
ement Report Corporate Governance Financial Statements Appendices Page 5 Management Report 6 Business and Operating Environment 7 Strategy, Business Model and Value Chain 12 Operating Environment 25 … |
| PARSE-BIOSCIENCES-INC |
PARSE-BIOSCIENCES-INC |
62%
|
. This growth has been driven by both organic expansion and strategic acquisitions, including the 2025 acquisitions of Parse Biosciences, Inc. and Genoox. We might continue acquiring businesses that … |
| PREANALYTIX-GMBH |
PREANALYTIX-GMBH |
62%
|
y. For the years ended December 31, 2025 , 2024 and 2023 , depreciation and amortization expense totaled $ 95.8 million , $ 91.5 million and $ 85.6 million , respectively. For the years ended Decembe… |
| QIAGEN-GMBH |
QIAGEN-GMBH |
62%
|
's internal control over financial reporting as of December 31, 2025 . Its reports are included in this Annual Report on Form 20-F beginning on page 91 . QIAGEN N.V. | Financial Report 2025 Managemen… |
| QIAGEN-SCIENCES-LLC |
QIAGEN-SCIENCES-LLC |
62%
|
res for property, plant and equipment totaled $201.0 million in 2025 , $167.2 million in 2024 and $149.7 million in 2023 . These capital expenditures were financed from operating cash flows, and we e… |
| WELLINGTON-INVESTMENT-ADVISORS-HOLDINGS |
WELLINGTON-INVESTMENT-ADVISORS-HOLDINGS |
62%
|
. (2) The 20,678,987 shares attributed to BlackRock, Inc. are reported as of January 31, 2026. Of the 20,678,987 shares attributed to BlackRock Inc. , it has sole voting power over 19,575,569 and sol… |
| WELLINGTON-MANAGEMENT-COMPANY |
WELLINGTON-MANAGEMENT-COMPANY |
62%
|
. (2) The 20,678,987 shares attributed to BlackRock, Inc. are reported as of January 31, 2026. Of the 20,678,987 shares attributed to BlackRock Inc. , it has sole voting power over 19,575,569 and sol… |
| WELLINGTON-MANAGEMENT-GROUP |
WELLINGTON-MANAGEMENT-GROUP |
62%
|
. (2) The 20,678,987 shares attributed to BlackRock, Inc. are reported as of January 31, 2026. Of the 20,678,987 shares attributed to BlackRock Inc. , it has sole voting power over 19,575,569 and sol… |
